Related Experiment Video
Updated: May 22, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
COMT Val158Met genotype influences neurodegeneration within dopamine-innervated brain structures
E D Gennatas1, J A Cholfin, J Zhou
1Memory and Aging Center, Department of Neurology, University of California-San Francisco, CA, USA.
Neurology
|May 11, 2012
Summary
The catechol-O-methyltransferase (COMT) Val(158)Met polymorphism impacts neurodegeneration in dopamine-rich brain areas. Val allele dosage correlates with gray matter loss, suggesting increased dopamine breakdown promotes neurodegeneration.
Area of Science:
- Neuroscience
- Genetics
- Neuroimaging
Background:
- Dopamine (DA) plays a crucial role in brain function.
- The catechol-O-methyltransferase (COMT) enzyme regulates dopamine levels.
- Genetic variations in COMT, such as the Val(158)Met polymorphism, can affect enzyme activity and dopamine availability.
Purpose of the Study:
- To investigate the association between the COMT Val(158)Met polymorphism and neurodegeneration in dopamine-innervated brain regions.
- To explore how COMT genotype influences brain structure in relation to dopamine pathways.
Main Methods:
- COMT genotyping was performed on 252 participants, including healthy controls and patients with neurodegenerative diseases.
- Structural Magnetic Resonance Imaging (MRI) was used to assess brain gray matter.
- Voxel-wise regression analyses were conducted to correlate COMT genotype with brain structure and cognitive/behavioral measures.
Main Results:
- Val allele dosage of the COMT Val(158)Met polymorphism was associated with reduced gray matter volume in key dopamine-innervated areas, including the ventral tegmental area (VTA) and prefrontal cortex.
- Individuals with a Met allele unexpectedly showed larger VTA volumes compared to controls.
- Gray matter integrity in COMT-associated regions correlated with cognitive and behavioral deficits.
Conclusions:
- The findings support the hypothesis that enhanced dopamine catabolism, influenced by the COMT Val allele, contributes to neurodegeneration in dopamine-related brain circuits.
- The COMT Val(158)Met polymorphism is a potential genetic factor influencing susceptibility to neurodegeneration in specific brain regions.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...